Germany's Merck has agreed to acquire Bio-Techne for $11 billion to strengthen its life sciences business. This was reported by Qazaqyia.kz citing Reuters.
The deal is aimed at boosting Merck's life sciences division. Bio-Techne is a supplier of biotechnology products and reagents. The acquisition is expected to expand Merck's research and production capabilities.